Neurones (XPAR:NRO) Accounts Payable: €69.7 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:NRO Neurones XPAR:NRO
91 GF Score
Price €36.00
GF Value €50.38
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Neurones Accounts Payable?

Neurones XPAR:NRO +2.56% 91 Accounts Payable is €69.7 Mil as of Dec. 2025. GuruFocus rates XPAR:NRO with a GF Score™ of 91/100 and a GF Value™ of €50.38 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Neurones's Accounts Payable for the quarter that ended in Dec. 2025 was €69.7 Mil.

Neurones's quarterly Accounts Payable declined from Dec. 2024 (€67.2 Mil) to Jun. 2025 (€59.5 Mil) but then increased from Jun. 2025 (€59.5 Mil) to Dec. 2025 (€69.7 Mil).

Neurones's annual Accounts Payable increased from Dec. 2023 (€44.0 Mil) to Dec. 2024 (€67.2 Mil) and increased from Dec. 2024 (€67.2 Mil) to Dec. 2025 (€69.7 Mil).

Neurones Accounts Payable Historical Data

* Premium members only.

The historical data trend for Neurones's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neurones Accounts Payable Chart

Neurones Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.73 42.93 44.04 67.23 69.65

Neurones Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.04 52.19 67.23 59.50 69.65
XPAR:NRO
91GF Score
Neurones XPAR:NRO
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Neurones Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of €69.7 Mil mean?
Neurones (XPAR:NRO) has a Accounts Payable of €69.7 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Neurones and its competitors.
Is Neurones' Accounts Payable too high?
Neurones' current Accounts Payable is €69.7 Mil. Overall, Neurones has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Neurones' Accounts Payable compare to IBM and ACN?
Neurones' Accounts Payable of €69.7 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Software company?
A good Accounts Payable depends on the Software industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Neurones and its competitors. Neurones's current Accounts Payable is €69.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neurones stock overvalued right now?
Based on GuruFocus' analysis, Neurones (XPAR:NRO) is currently considered Modestly Undervalued. The stock's GF Value™ is €50.38, compared to a current price of €36.00 — trading 28.5% below its estimated fair value. The current Accounts Payable is €69.7 Mil. Neurones' overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Neurones (XPAR:NRO), the current Accounts Payable is €69.7 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Neurones (XPAR:NRO) Overvalued in 2026?

Based on GuruFocus' analysis, Neurones stock appears to be undervalued. The current stock price of €36.00 is trading 28.5% below its estimated GF Value™ of €50.38. GuruFocus considers Neurones to be Modestly Undervalued.

Key valuation signals for XPAR:NRO:

  • Accounts Payable: €69.7 Mil
  • GF Value™: €50.38 vs. price of €36.00 (28.5% below fair value)
  • GF Score™: 91/100 with 3 warning signs

No single metric tells the full story. See the XPAR:NRO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Neurones Business Description

Other Exchanges 0GX2:UKNE9:Germany
Address 205 Avenue Georges Clemenceau, Immeuble Le Clemenceau 1 Building, Nanterre, FRA, 92024
Neurones is active in Consulting and Digital Services, with activities including Digital Transformation, Overall Offer, Infrastructure Hub, Applications Hub, Consulting Division, Managed Services, and Service Centers. It also conducts IT development, pre-sales activities, management of fixed-price projects, technical assistance, infrastructure operations, and cybersecurity, and provides an internal platform for multi-LLM assistants, including Microsoft Copilot, ChatGPT, Gemini, Claude, and Mistral. Its segments are Infrastructure Services, Application Services, and Consulting. Infrastructure Services generates the majority of revenue and includes Cloud, Infrastructure Management, DevOps, Cybersecurity, User Support, IT Service Management, Information System Governance, and Automation.
91GF Score

Get the complete analysis for XPAR:NRO

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€36.00
Price
€50.38
GF Value